INT J BIOL MACROMOL 润色咨询

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

出版年份：1979 年文章数：16068 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：16.7% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2141072, encodeId=008d21410e2f0, content=10号投稿，当天with editor。15号变成decision，现在还在等待决定。已经快一个月了，有相同经历的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb75418039, createdName=gyoun9, createdTime=Tue Jun 06 14:51:37 CST 2023, time=2023-06-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2162463, encodeId=8ce221624639f, content=投稿7个月了，外审时间都半年了，催了几次回复都一样。问一下大家，是不是审稿人不回复，编辑就一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rRiaicFp2D5Zialtibib5bH8Xicoiaa0UkU4YtcrrAfpFuwiaAlBPjztFLu3icxdzV1zkf1wYjZRbfdCsLEUtic5XuGWY1HQ/132, createdBy=b6f92385679, createdName=superzera, createdTime=Thu Oct 12 21:40:23 CST 2023, time=2023-10-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2154515, encodeId=37f22154515ce, content=这个刊物最近是怎么了呀，感觉处理速度好慢，7.31早上就with editor，到现在状态一点没变，NC也不至于with editor一个月吧，听说这个杂志催编辑压根没用，已经开始焦虑了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26b85400525, createdName=Aab12w3, createdTime=Fri Aug 25 11:20:16 CST 2023, time=2023-08-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2158669, encodeId=ca45215866945, content=偏重的研究方向：肿瘤;药物化学<br>经验分享：有没有是cancer letter让转投过来的？机会大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/9883684c50eb4525aa0007900c15ab09/c44d99673a04497daa77b8386586df68.jpg, createdBy=70f62430863, createdName=lovebanana, createdTime=Wed Sep 20 10:18:43 CST 2023, time=2023-09-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1063446, encodeId=f96a1063446fd, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：多糖综述<br>经验分享：10月10号投稿，过去半个月了，现在还在With Editor，请问这种情况可以联系编辑吗？怎么联系呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62081980628, createdName=1e180d0dm79(暂无匿称), createdTime=Sun Oct 24 14:32:17 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106235, encodeId=347b210623503, content=投稿一个月了，还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211226/b81eecd114f947a4b95c452618e5ebdc/32dc8969e6744e21929a0d643f10b777.jpg, createdBy=404c107315, createdName=Marvin2014, createdTime=Thu Dec 15 20:44:34 CST 2022, time=2022-12-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=950107, encodeId=c72995010e59, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:3000.0<br>偏重的研究方向：蛋白;结构<br>经验分享：我的投稿速度应该算是这个杂志的平均速度。<br>投出去一天with editor；<br>5天under review；<br>14天获得外省意见；<br>22天major review，给了28天修回；<br>二审20天，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90331723198, createdName=璎, createdTime=Mon Mar 22 14:56:24 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861661, encodeId=c8378616612b, content=审稿速度:3.0<br>经验分享：2020.3.15 submit，with editor，4天<br> 2020.3.19 under review，25天<br> 2020.4.9 revision request（major revision），两个审稿人 提了10左右问题,14天<br> 2020.4.22 re-submit，with editor，1天<br> 2020.4.23 under review， 45天<br> 2020.6.8 accept<br> 编辑效率非常高，总体挺顺利的 ，祝大家文章都能早日接收，期刊越办越好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6f95414014, createdName=ms9686134410729756, createdTime=Wed Jun 10 06:33:48 CST 2020, time=2020-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向：分子生物学<br>经验分享：投稿第三天直接decision in process 请问这是直接拒稿吗？有没有相同经历的人 麻烦分享一下 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=806078, encodeId=ed098060e89d, content=我这为什么昨天刚投稿，今天就是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f945319034, createdName=148a44dcm02暂无昵称, createdTime=Tue Aug 04 10:21:36 CST 2020, time=2020-08-04, status=1, ipAttribution=)]
    2023-06-06 gyoun9 来自北京

    10号投稿，当天with editor。15号变成decision，现在还在等待决定。已经快一个月了，有相同经历的朋友吗

    15

    展开15条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2141072, encodeId=008d21410e2f0, content=10号投稿，当天with editor。15号变成decision，现在还在等待决定。已经快一个月了，有相同经历的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb75418039, createdName=gyoun9, createdTime=Tue Jun 06 14:51:37 CST 2023, time=2023-06-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2162463, encodeId=8ce221624639f, content=投稿7个月了，外审时间都半年了，催了几次回复都一样。问一下大家，是不是审稿人不回复，编辑就一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rRiaicFp2D5Zialtibib5bH8Xicoiaa0UkU4YtcrrAfpFuwiaAlBPjztFLu3icxdzV1zkf1wYjZRbfdCsLEUtic5XuGWY1HQ/132, createdBy=b6f92385679, createdName=superzera, createdTime=Thu Oct 12 21:40:23 CST 2023, time=2023-10-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2154515, encodeId=37f22154515ce, content=这个刊物最近是怎么了呀，感觉处理速度好慢，7.31早上就with editor，到现在状态一点没变，NC也不至于with editor一个月吧，听说这个杂志催编辑压根没用，已经开始焦虑了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26b85400525, createdName=Aab12w3, createdTime=Fri Aug 25 11:20:16 CST 2023, time=2023-08-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2158669, encodeId=ca45215866945, content=偏重的研究方向：肿瘤;药物化学<br>经验分享：有没有是cancer letter让转投过来的？机会大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/9883684c50eb4525aa0007900c15ab09/c44d99673a04497daa77b8386586df68.jpg, createdBy=70f62430863, createdName=lovebanana, createdTime=Wed Sep 20 10:18:43 CST 2023, time=2023-09-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1063446, encodeId=f96a1063446fd, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：多糖综述<br>经验分享：10月10号投稿，过去半个月了，现在还在With Editor，请问这种情况可以联系编辑吗？怎么联系呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62081980628, createdName=1e180d0dm79(暂无匿称), createdTime=Sun Oct 24 14:32:17 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106235, encodeId=347b210623503, content=投稿一个月了，还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211226/b81eecd114f947a4b95c452618e5ebdc/32dc8969e6744e21929a0d643f10b777.jpg, createdBy=404c107315, createdName=Marvin2014, createdTime=Thu Dec 15 20:44:34 CST 2022, time=2022-12-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=950107, encodeId=c72995010e59, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:3000.0<br>偏重的研究方向：蛋白;结构<br>经验分享：我的投稿速度应该算是这个杂志的平均速度。<br>投出去一天with editor；<br>5天under review；<br>14天获得外省意见；<br>22天major review，给了28天修回；<br>二审20天，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90331723198, createdName=璎, createdTime=Mon Mar 22 14:56:24 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861661, encodeId=c8378616612b, content=审稿速度:3.0<br>经验分享：2020.3.15 submit，with editor，4天<br> 2020.3.19 under review，25天<br> 2020.4.9 revision request（major revision），两个审稿人 提了10左右问题,14天<br> 2020.4.22 re-submit，with editor，1天<br> 2020.4.23 under review， 45天<br> 2020.6.8 accept<br> 编辑效率非常高，总体挺顺利的 ，祝大家文章都能早日接收，期刊越办越好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6f95414014, createdName=ms9686134410729756, createdTime=Wed Jun 10 06:33:48 CST 2020, time=2020-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向：分子生物学<br>经验分享：投稿第三天直接decision in process 请问这是直接拒稿吗？有没有相同经历的人 麻烦分享一下 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=806078, encodeId=ed098060e89d, content=我这为什么昨天刚投稿，今天就是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f945319034, createdName=148a44dcm02暂无昵称, createdTime=Tue Aug 04 10:21:36 CST 2020, time=2020-08-04, status=1, ipAttribution=)]
    2023-10-12 superzera 来自广东省

    投稿7个月了，外审时间都半年了，催了几次回复都一样。问一下大家，是不是审稿人不回复，编辑就一直等

    14

    展开14条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2141072, encodeId=008d21410e2f0, content=10号投稿，当天with editor。15号变成decision，现在还在等待决定。已经快一个月了，有相同经历的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb75418039, createdName=gyoun9, createdTime=Tue Jun 06 14:51:37 CST 2023, time=2023-06-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2162463, encodeId=8ce221624639f, content=投稿7个月了，外审时间都半年了，催了几次回复都一样。问一下大家，是不是审稿人不回复，编辑就一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rRiaicFp2D5Zialtibib5bH8Xicoiaa0UkU4YtcrrAfpFuwiaAlBPjztFLu3icxdzV1zkf1wYjZRbfdCsLEUtic5XuGWY1HQ/132, createdBy=b6f92385679, createdName=superzera, createdTime=Thu Oct 12 21:40:23 CST 2023, time=2023-10-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2154515, encodeId=37f22154515ce, content=这个刊物最近是怎么了呀，感觉处理速度好慢，7.31早上就with editor，到现在状态一点没变，NC也不至于with editor一个月吧，听说这个杂志催编辑压根没用，已经开始焦虑了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26b85400525, createdName=Aab12w3, createdTime=Fri Aug 25 11:20:16 CST 2023, time=2023-08-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2158669, encodeId=ca45215866945, content=偏重的研究方向：肿瘤;药物化学<br>经验分享：有没有是cancer letter让转投过来的？机会大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/9883684c50eb4525aa0007900c15ab09/c44d99673a04497daa77b8386586df68.jpg, createdBy=70f62430863, createdName=lovebanana, createdTime=Wed Sep 20 10:18:43 CST 2023, time=2023-09-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1063446, encodeId=f96a1063446fd, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：多糖综述<br>经验分享：10月10号投稿，过去半个月了，现在还在With Editor，请问这种情况可以联系编辑吗？怎么联系呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62081980628, createdName=1e180d0dm79(暂无匿称), createdTime=Sun Oct 24 14:32:17 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106235, encodeId=347b210623503, content=投稿一个月了，还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211226/b81eecd114f947a4b95c452618e5ebdc/32dc8969e6744e21929a0d643f10b777.jpg, createdBy=404c107315, createdName=Marvin2014, createdTime=Thu Dec 15 20:44:34 CST 2022, time=2022-12-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=950107, encodeId=c72995010e59, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:3000.0<br>偏重的研究方向：蛋白;结构<br>经验分享：我的投稿速度应该算是这个杂志的平均速度。<br>投出去一天with editor；<br>5天under review；<br>14天获得外省意见；<br>22天major review，给了28天修回；<br>二审20天，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90331723198, createdName=璎, createdTime=Mon Mar 22 14:56:24 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861661, encodeId=c8378616612b, content=审稿速度:3.0<br>经验分享：2020.3.15 submit，with editor，4天<br> 2020.3.19 under review，25天<br> 2020.4.9 revision request（major revision），两个审稿人 提了10左右问题,14天<br> 2020.4.22 re-submit，with editor，1天<br> 2020.4.23 under review， 45天<br> 2020.6.8 accept<br> 编辑效率非常高，总体挺顺利的 ，祝大家文章都能早日接收，期刊越办越好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6f95414014, createdName=ms9686134410729756, createdTime=Wed Jun 10 06:33:48 CST 2020, time=2020-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向：分子生物学<br>经验分享：投稿第三天直接decision in process 请问这是直接拒稿吗？有没有相同经历的人 麻烦分享一下 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=806078, encodeId=ed098060e89d, content=我这为什么昨天刚投稿，今天就是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f945319034, createdName=148a44dcm02暂无昵称, createdTime=Tue Aug 04 10:21:36 CST 2020, time=2020-08-04, status=1, ipAttribution=)]
    2023-08-25 Aab12w3 来自北京

    这个刊物最近是怎么了呀，感觉处理速度好慢，7.31早上就with editor，到现在状态一点没变，NC也不至于with editor一个月吧，听说这个杂志催编辑压根没用，已经开始焦虑了。。。

    12

    展开12条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2141072, encodeId=008d21410e2f0, content=10号投稿，当天with editor。15号变成decision，现在还在等待决定。已经快一个月了，有相同经历的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb75418039, createdName=gyoun9, createdTime=Tue Jun 06 14:51:37 CST 2023, time=2023-06-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2162463, encodeId=8ce221624639f, content=投稿7个月了，外审时间都半年了，催了几次回复都一样。问一下大家，是不是审稿人不回复，编辑就一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rRiaicFp2D5Zialtibib5bH8Xicoiaa0UkU4YtcrrAfpFuwiaAlBPjztFLu3icxdzV1zkf1wYjZRbfdCsLEUtic5XuGWY1HQ/132, createdBy=b6f92385679, createdName=superzera, createdTime=Thu Oct 12 21:40:23 CST 2023, time=2023-10-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2154515, encodeId=37f22154515ce, content=这个刊物最近是怎么了呀，感觉处理速度好慢，7.31早上就with editor，到现在状态一点没变，NC也不至于with editor一个月吧，听说这个杂志催编辑压根没用，已经开始焦虑了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26b85400525, createdName=Aab12w3, createdTime=Fri Aug 25 11:20:16 CST 2023, time=2023-08-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2158669, encodeId=ca45215866945, content=偏重的研究方向：肿瘤;药物化学<br>经验分享：有没有是cancer letter让转投过来的？机会大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/9883684c50eb4525aa0007900c15ab09/c44d99673a04497daa77b8386586df68.jpg, createdBy=70f62430863, createdName=lovebanana, createdTime=Wed Sep 20 10:18:43 CST 2023, time=2023-09-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1063446, encodeId=f96a1063446fd, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：多糖综述<br>经验分享：10月10号投稿，过去半个月了，现在还在With Editor，请问这种情况可以联系编辑吗？怎么联系呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62081980628, createdName=1e180d0dm79(暂无匿称), createdTime=Sun Oct 24 14:32:17 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106235, encodeId=347b210623503, content=投稿一个月了，还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211226/b81eecd114f947a4b95c452618e5ebdc/32dc8969e6744e21929a0d643f10b777.jpg, createdBy=404c107315, createdName=Marvin2014, createdTime=Thu Dec 15 20:44:34 CST 2022, time=2022-12-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=950107, encodeId=c72995010e59, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:3000.0<br>偏重的研究方向：蛋白;结构<br>经验分享：我的投稿速度应该算是这个杂志的平均速度。<br>投出去一天with editor；<br>5天under review；<br>14天获得外省意见；<br>22天major review，给了28天修回；<br>二审20天，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90331723198, createdName=璎, createdTime=Mon Mar 22 14:56:24 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861661, encodeId=c8378616612b, content=审稿速度:3.0<br>经验分享：2020.3.15 submit，with editor，4天<br> 2020.3.19 under review，25天<br> 2020.4.9 revision request（major revision），两个审稿人 提了10左右问题,14天<br> 2020.4.22 re-submit，with editor，1天<br> 2020.4.23 under review， 45天<br> 2020.6.8 accept<br> 编辑效率非常高，总体挺顺利的 ，祝大家文章都能早日接收，期刊越办越好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6f95414014, createdName=ms9686134410729756, createdTime=Wed Jun 10 06:33:48 CST 2020, time=2020-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向：分子生物学<br>经验分享：投稿第三天直接decision in process 请问这是直接拒稿吗？有没有相同经历的人 麻烦分享一下 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=806078, encodeId=ed098060e89d, content=我这为什么昨天刚投稿，今天就是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f945319034, createdName=148a44dcm02暂无昵称, createdTime=Tue Aug 04 10:21:36 CST 2020, time=2020-08-04, status=1, ipAttribution=)]
    2023-09-20 lovebanana 来自江苏省

    偏重的研究方向：肿瘤;药物化学
    经验分享：有没有是cancer letter让转投过来的？机会大不大？

    10

    展开10条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2141072, encodeId=008d21410e2f0, content=10号投稿，当天with editor。15号变成decision，现在还在等待决定。已经快一个月了，有相同经历的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb75418039, createdName=gyoun9, createdTime=Tue Jun 06 14:51:37 CST 2023, time=2023-06-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2162463, encodeId=8ce221624639f, content=投稿7个月了，外审时间都半年了，催了几次回复都一样。问一下大家，是不是审稿人不回复，编辑就一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rRiaicFp2D5Zialtibib5bH8Xicoiaa0UkU4YtcrrAfpFuwiaAlBPjztFLu3icxdzV1zkf1wYjZRbfdCsLEUtic5XuGWY1HQ/132, createdBy=b6f92385679, createdName=superzera, createdTime=Thu Oct 12 21:40:23 CST 2023, time=2023-10-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2154515, encodeId=37f22154515ce, content=这个刊物最近是怎么了呀，感觉处理速度好慢，7.31早上就with editor，到现在状态一点没变，NC也不至于with editor一个月吧，听说这个杂志催编辑压根没用，已经开始焦虑了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26b85400525, createdName=Aab12w3, createdTime=Fri Aug 25 11:20:16 CST 2023, time=2023-08-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2158669, encodeId=ca45215866945, content=偏重的研究方向：肿瘤;药物化学<br>经验分享：有没有是cancer letter让转投过来的？机会大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/9883684c50eb4525aa0007900c15ab09/c44d99673a04497daa77b8386586df68.jpg, createdBy=70f62430863, createdName=lovebanana, createdTime=Wed Sep 20 10:18:43 CST 2023, time=2023-09-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1063446, encodeId=f96a1063446fd, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：多糖综述<br>经验分享：10月10号投稿，过去半个月了，现在还在With Editor，请问这种情况可以联系编辑吗？怎么联系呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62081980628, createdName=1e180d0dm79(暂无匿称), createdTime=Sun Oct 24 14:32:17 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106235, encodeId=347b210623503, content=投稿一个月了，还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211226/b81eecd114f947a4b95c452618e5ebdc/32dc8969e6744e21929a0d643f10b777.jpg, createdBy=404c107315, createdName=Marvin2014, createdTime=Thu Dec 15 20:44:34 CST 2022, time=2022-12-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=950107, encodeId=c72995010e59, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:3000.0<br>偏重的研究方向：蛋白;结构<br>经验分享：我的投稿速度应该算是这个杂志的平均速度。<br>投出去一天with editor；<br>5天under review；<br>14天获得外省意见；<br>22天major review，给了28天修回；<br>二审20天，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90331723198, createdName=璎, createdTime=Mon Mar 22 14:56:24 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861661, encodeId=c8378616612b, content=审稿速度:3.0<br>经验分享：2020.3.15 submit，with editor，4天<br> 2020.3.19 under review，25天<br> 2020.4.9 revision request（major revision），两个审稿人 提了10左右问题,14天<br> 2020.4.22 re-submit，with editor，1天<br> 2020.4.23 under review， 45天<br> 2020.6.8 accept<br> 编辑效率非常高，总体挺顺利的 ，祝大家文章都能早日接收，期刊越办越好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6f95414014, createdName=ms9686134410729756, createdTime=Wed Jun 10 06:33:48 CST 2020, time=2020-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向：分子生物学<br>经验分享：投稿第三天直接decision in process 请问这是直接拒稿吗？有没有相同经历的人 麻烦分享一下 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=806078, encodeId=ed098060e89d, content=我这为什么昨天刚投稿，今天就是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f945319034, createdName=148a44dcm02暂无昵称, createdTime=Tue Aug 04 10:21:36 CST 2020, time=2020-08-04, status=1, ipAttribution=)]
    2021-10-24 1e180d0dm79(暂无匿称)

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向：多糖综述
    经验分享：10月10号投稿，过去半个月了，现在还在With Editor，请问这种情况可以联系编辑吗？怎么联系呢？

    10

    展开10条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2141072, encodeId=008d21410e2f0, content=10号投稿，当天with editor。15号变成decision，现在还在等待决定。已经快一个月了，有相同经历的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb75418039, createdName=gyoun9, createdTime=Tue Jun 06 14:51:37 CST 2023, time=2023-06-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2162463, encodeId=8ce221624639f, content=投稿7个月了，外审时间都半年了，催了几次回复都一样。问一下大家，是不是审稿人不回复，编辑就一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rRiaicFp2D5Zialtibib5bH8Xicoiaa0UkU4YtcrrAfpFuwiaAlBPjztFLu3icxdzV1zkf1wYjZRbfdCsLEUtic5XuGWY1HQ/132, createdBy=b6f92385679, createdName=superzera, createdTime=Thu Oct 12 21:40:23 CST 2023, time=2023-10-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2154515, encodeId=37f22154515ce, content=这个刊物最近是怎么了呀，感觉处理速度好慢，7.31早上就with editor，到现在状态一点没变，NC也不至于with editor一个月吧，听说这个杂志催编辑压根没用，已经开始焦虑了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26b85400525, createdName=Aab12w3, createdTime=Fri Aug 25 11:20:16 CST 2023, time=2023-08-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2158669, encodeId=ca45215866945, content=偏重的研究方向：肿瘤;药物化学<br>经验分享：有没有是cancer letter让转投过来的？机会大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/9883684c50eb4525aa0007900c15ab09/c44d99673a04497daa77b8386586df68.jpg, createdBy=70f62430863, createdName=lovebanana, createdTime=Wed Sep 20 10:18:43 CST 2023, time=2023-09-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1063446, encodeId=f96a1063446fd, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：多糖综述<br>经验分享：10月10号投稿，过去半个月了，现在还在With Editor，请问这种情况可以联系编辑吗？怎么联系呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62081980628, createdName=1e180d0dm79(暂无匿称), createdTime=Sun Oct 24 14:32:17 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106235, encodeId=347b210623503, content=投稿一个月了，还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211226/b81eecd114f947a4b95c452618e5ebdc/32dc8969e6744e21929a0d643f10b777.jpg, createdBy=404c107315, createdName=Marvin2014, createdTime=Thu Dec 15 20:44:34 CST 2022, time=2022-12-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=950107, encodeId=c72995010e59, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:3000.0<br>偏重的研究方向：蛋白;结构<br>经验分享：我的投稿速度应该算是这个杂志的平均速度。<br>投出去一天with editor；<br>5天under review；<br>14天获得外省意见；<br>22天major review，给了28天修回；<br>二审20天，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90331723198, createdName=璎, createdTime=Mon Mar 22 14:56:24 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861661, encodeId=c8378616612b, content=审稿速度:3.0<br>经验分享：2020.3.15 submit，with editor，4天<br> 2020.3.19 under review，25天<br> 2020.4.9 revision request（major revision），两个审稿人 提了10左右问题,14天<br> 2020.4.22 re-submit，with editor，1天<br> 2020.4.23 under review， 45天<br> 2020.6.8 accept<br> 编辑效率非常高，总体挺顺利的 ，祝大家文章都能早日接收，期刊越办越好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6f95414014, createdName=ms9686134410729756, createdTime=Wed Jun 10 06:33:48 CST 2020, time=2020-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向：分子生物学<br>经验分享：投稿第三天直接decision in process 请问这是直接拒稿吗？有没有相同经历的人 麻烦分享一下 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=806078, encodeId=ed098060e89d, content=我这为什么昨天刚投稿，今天就是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f945319034, createdName=148a44dcm02暂无昵称, createdTime=Tue Aug 04 10:21:36 CST 2020, time=2020-08-04, status=1, ipAttribution=)]
    2022-12-15 Marvin2014 来自江苏省

    投稿一个月了，还在under review

    9

    展开9条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2141072, encodeId=008d21410e2f0, content=10号投稿，当天with editor。15号变成decision，现在还在等待决定。已经快一个月了，有相同经历的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb75418039, createdName=gyoun9, createdTime=Tue Jun 06 14:51:37 CST 2023, time=2023-06-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2162463, encodeId=8ce221624639f, content=投稿7个月了，外审时间都半年了，催了几次回复都一样。问一下大家，是不是审稿人不回复，编辑就一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rRiaicFp2D5Zialtibib5bH8Xicoiaa0UkU4YtcrrAfpFuwiaAlBPjztFLu3icxdzV1zkf1wYjZRbfdCsLEUtic5XuGWY1HQ/132, createdBy=b6f92385679, createdName=superzera, createdTime=Thu Oct 12 21:40:23 CST 2023, time=2023-10-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2154515, encodeId=37f22154515ce, content=这个刊物最近是怎么了呀，感觉处理速度好慢，7.31早上就with editor，到现在状态一点没变，NC也不至于with editor一个月吧，听说这个杂志催编辑压根没用，已经开始焦虑了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26b85400525, createdName=Aab12w3, createdTime=Fri Aug 25 11:20:16 CST 2023, time=2023-08-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2158669, encodeId=ca45215866945, content=偏重的研究方向：肿瘤;药物化学<br>经验分享：有没有是cancer letter让转投过来的？机会大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/9883684c50eb4525aa0007900c15ab09/c44d99673a04497daa77b8386586df68.jpg, createdBy=70f62430863, createdName=lovebanana, createdTime=Wed Sep 20 10:18:43 CST 2023, time=2023-09-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1063446, encodeId=f96a1063446fd, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：多糖综述<br>经验分享：10月10号投稿，过去半个月了，现在还在With Editor，请问这种情况可以联系编辑吗？怎么联系呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62081980628, createdName=1e180d0dm79(暂无匿称), createdTime=Sun Oct 24 14:32:17 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106235, encodeId=347b210623503, content=投稿一个月了，还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211226/b81eecd114f947a4b95c452618e5ebdc/32dc8969e6744e21929a0d643f10b777.jpg, createdBy=404c107315, createdName=Marvin2014, createdTime=Thu Dec 15 20:44:34 CST 2022, time=2022-12-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=950107, encodeId=c72995010e59, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:3000.0<br>偏重的研究方向：蛋白;结构<br>经验分享：我的投稿速度应该算是这个杂志的平均速度。<br>投出去一天with editor；<br>5天under review；<br>14天获得外省意见；<br>22天major review，给了28天修回；<br>二审20天，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90331723198, createdName=璎, createdTime=Mon Mar 22 14:56:24 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861661, encodeId=c8378616612b, content=审稿速度:3.0<br>经验分享：2020.3.15 submit，with editor，4天<br> 2020.3.19 under review，25天<br> 2020.4.9 revision request（major revision），两个审稿人 提了10左右问题,14天<br> 2020.4.22 re-submit，with editor，1天<br> 2020.4.23 under review， 45天<br> 2020.6.8 accept<br> 编辑效率非常高，总体挺顺利的 ，祝大家文章都能早日接收，期刊越办越好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6f95414014, createdName=ms9686134410729756, createdTime=Wed Jun 10 06:33:48 CST 2020, time=2020-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向：分子生物学<br>经验分享：投稿第三天直接decision in process 请问这是直接拒稿吗？有没有相同经历的人 麻烦分享一下 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=806078, encodeId=ed098060e89d, content=我这为什么昨天刚投稿，今天就是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f945319034, createdName=148a44dcm02暂无昵称, createdTime=Tue Aug 04 10:21:36 CST 2020, time=2020-08-04, status=1, ipAttribution=)]
    2021-03-22 璎

    审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:3000.0
    偏重的研究方向：蛋白;结构
    经验分享：我的投稿速度应该算是这个杂志的平均速度。
    投出去一天with editor；
    5天under review；
    14天获得外省意见；
    22天major review，给了28天修回；
    二审20天，接收。

    9

    展开9条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2141072, encodeId=008d21410e2f0, content=10号投稿，当天with editor。15号变成decision，现在还在等待决定。已经快一个月了，有相同经历的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb75418039, createdName=gyoun9, createdTime=Tue Jun 06 14:51:37 CST 2023, time=2023-06-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2162463, encodeId=8ce221624639f, content=投稿7个月了，外审时间都半年了，催了几次回复都一样。问一下大家，是不是审稿人不回复，编辑就一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rRiaicFp2D5Zialtibib5bH8Xicoiaa0UkU4YtcrrAfpFuwiaAlBPjztFLu3icxdzV1zkf1wYjZRbfdCsLEUtic5XuGWY1HQ/132, createdBy=b6f92385679, createdName=superzera, createdTime=Thu Oct 12 21:40:23 CST 2023, time=2023-10-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2154515, encodeId=37f22154515ce, content=这个刊物最近是怎么了呀，感觉处理速度好慢，7.31早上就with editor，到现在状态一点没变，NC也不至于with editor一个月吧，听说这个杂志催编辑压根没用，已经开始焦虑了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26b85400525, createdName=Aab12w3, createdTime=Fri Aug 25 11:20:16 CST 2023, time=2023-08-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2158669, encodeId=ca45215866945, content=偏重的研究方向：肿瘤;药物化学<br>经验分享：有没有是cancer letter让转投过来的？机会大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/9883684c50eb4525aa0007900c15ab09/c44d99673a04497daa77b8386586df68.jpg, createdBy=70f62430863, createdName=lovebanana, createdTime=Wed Sep 20 10:18:43 CST 2023, time=2023-09-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1063446, encodeId=f96a1063446fd, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：多糖综述<br>经验分享：10月10号投稿，过去半个月了，现在还在With Editor，请问这种情况可以联系编辑吗？怎么联系呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62081980628, createdName=1e180d0dm79(暂无匿称), createdTime=Sun Oct 24 14:32:17 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106235, encodeId=347b210623503, content=投稿一个月了，还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211226/b81eecd114f947a4b95c452618e5ebdc/32dc8969e6744e21929a0d643f10b777.jpg, createdBy=404c107315, createdName=Marvin2014, createdTime=Thu Dec 15 20:44:34 CST 2022, time=2022-12-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=950107, encodeId=c72995010e59, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:3000.0<br>偏重的研究方向：蛋白;结构<br>经验分享：我的投稿速度应该算是这个杂志的平均速度。<br>投出去一天with editor；<br>5天under review；<br>14天获得外省意见；<br>22天major review，给了28天修回；<br>二审20天，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90331723198, createdName=璎, createdTime=Mon Mar 22 14:56:24 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861661, encodeId=c8378616612b, content=审稿速度:3.0<br>经验分享：2020.3.15 submit，with editor，4天<br> 2020.3.19 under review，25天<br> 2020.4.9 revision request（major revision），两个审稿人 提了10左右问题,14天<br> 2020.4.22 re-submit，with editor，1天<br> 2020.4.23 under review， 45天<br> 2020.6.8 accept<br> 编辑效率非常高，总体挺顺利的 ，祝大家文章都能早日接收，期刊越办越好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6f95414014, createdName=ms9686134410729756, createdTime=Wed Jun 10 06:33:48 CST 2020, time=2020-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向：分子生物学<br>经验分享：投稿第三天直接decision in process 请问这是直接拒稿吗？有没有相同经历的人 麻烦分享一下 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=806078, encodeId=ed098060e89d, content=我这为什么昨天刚投稿，今天就是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f945319034, createdName=148a44dcm02暂无昵称, createdTime=Tue Aug 04 10:21:36 CST 2020, time=2020-08-04, status=1, ipAttribution=)]
    2020-06-10 ms9686134410729756

    审稿速度:3.0
    经验分享：2020.3.15 submit，with editor，4天
    2020.3.19 under review，25天
    2020.4.9 revision request（major revision），两个审稿人 提了10左右问题,14天
    2020.4.22 re-submit，with editor，1天
    2020.4.23 under review， 45天
    2020.6.8 accept
    编辑效率非常高，总体挺顺利的 ，祝大家文章都能早日接收，期刊越办越好。

    9

    展开9条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2141072, encodeId=008d21410e2f0, content=10号投稿，当天with editor。15号变成decision，现在还在等待决定。已经快一个月了，有相同经历的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb75418039, createdName=gyoun9, createdTime=Tue Jun 06 14:51:37 CST 2023, time=2023-06-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2162463, encodeId=8ce221624639f, content=投稿7个月了，外审时间都半年了，催了几次回复都一样。问一下大家，是不是审稿人不回复，编辑就一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rRiaicFp2D5Zialtibib5bH8Xicoiaa0UkU4YtcrrAfpFuwiaAlBPjztFLu3icxdzV1zkf1wYjZRbfdCsLEUtic5XuGWY1HQ/132, createdBy=b6f92385679, createdName=superzera, createdTime=Thu Oct 12 21:40:23 CST 2023, time=2023-10-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2154515, encodeId=37f22154515ce, content=这个刊物最近是怎么了呀，感觉处理速度好慢，7.31早上就with editor，到现在状态一点没变，NC也不至于with editor一个月吧，听说这个杂志催编辑压根没用，已经开始焦虑了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26b85400525, createdName=Aab12w3, createdTime=Fri Aug 25 11:20:16 CST 2023, time=2023-08-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2158669, encodeId=ca45215866945, content=偏重的研究方向：肿瘤;药物化学<br>经验分享：有没有是cancer letter让转投过来的？机会大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/9883684c50eb4525aa0007900c15ab09/c44d99673a04497daa77b8386586df68.jpg, createdBy=70f62430863, createdName=lovebanana, createdTime=Wed Sep 20 10:18:43 CST 2023, time=2023-09-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1063446, encodeId=f96a1063446fd, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：多糖综述<br>经验分享：10月10号投稿，过去半个月了，现在还在With Editor，请问这种情况可以联系编辑吗？怎么联系呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62081980628, createdName=1e180d0dm79(暂无匿称), createdTime=Sun Oct 24 14:32:17 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106235, encodeId=347b210623503, content=投稿一个月了，还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211226/b81eecd114f947a4b95c452618e5ebdc/32dc8969e6744e21929a0d643f10b777.jpg, createdBy=404c107315, createdName=Marvin2014, createdTime=Thu Dec 15 20:44:34 CST 2022, time=2022-12-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=950107, encodeId=c72995010e59, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:3000.0<br>偏重的研究方向：蛋白;结构<br>经验分享：我的投稿速度应该算是这个杂志的平均速度。<br>投出去一天with editor；<br>5天under review；<br>14天获得外省意见；<br>22天major review，给了28天修回；<br>二审20天，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90331723198, createdName=璎, createdTime=Mon Mar 22 14:56:24 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861661, encodeId=c8378616612b, content=审稿速度:3.0<br>经验分享：2020.3.15 submit，with editor，4天<br> 2020.3.19 under review，25天<br> 2020.4.9 revision request（major revision），两个审稿人 提了10左右问题,14天<br> 2020.4.22 re-submit，with editor，1天<br> 2020.4.23 under review， 45天<br> 2020.6.8 accept<br> 编辑效率非常高，总体挺顺利的 ，祝大家文章都能早日接收，期刊越办越好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6f95414014, createdName=ms9686134410729756, createdTime=Wed Jun 10 06:33:48 CST 2020, time=2020-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向：分子生物学<br>经验分享：投稿第三天直接decision in process 请问这是直接拒稿吗？有没有相同经历的人 麻烦分享一下 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=806078, encodeId=ed098060e89d, content=我这为什么昨天刚投稿，今天就是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f945319034, createdName=148a44dcm02暂无昵称, createdTime=Tue Aug 04 10:21:36 CST 2020, time=2020-08-04, status=1, ipAttribution=)]
    2023-09-11 Markxiao 来自香港

    偏重的研究方向：分子生物学
    经验分享：投稿第三天直接decision in process 请问这是直接拒稿吗？有没有相同经历的人 麻烦分享一下 谢谢

    6

    展开6条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2141072, encodeId=008d21410e2f0, content=10号投稿，当天with editor。15号变成decision，现在还在等待决定。已经快一个月了，有相同经历的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb75418039, createdName=gyoun9, createdTime=Tue Jun 06 14:51:37 CST 2023, time=2023-06-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2162463, encodeId=8ce221624639f, content=投稿7个月了，外审时间都半年了，催了几次回复都一样。问一下大家，是不是审稿人不回复，编辑就一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rRiaicFp2D5Zialtibib5bH8Xicoiaa0UkU4YtcrrAfpFuwiaAlBPjztFLu3icxdzV1zkf1wYjZRbfdCsLEUtic5XuGWY1HQ/132, createdBy=b6f92385679, createdName=superzera, createdTime=Thu Oct 12 21:40:23 CST 2023, time=2023-10-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2154515, encodeId=37f22154515ce, content=这个刊物最近是怎么了呀，感觉处理速度好慢，7.31早上就with editor，到现在状态一点没变，NC也不至于with editor一个月吧，听说这个杂志催编辑压根没用，已经开始焦虑了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26b85400525, createdName=Aab12w3, createdTime=Fri Aug 25 11:20:16 CST 2023, time=2023-08-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2158669, encodeId=ca45215866945, content=偏重的研究方向：肿瘤;药物化学<br>经验分享：有没有是cancer letter让转投过来的？机会大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/9883684c50eb4525aa0007900c15ab09/c44d99673a04497daa77b8386586df68.jpg, createdBy=70f62430863, createdName=lovebanana, createdTime=Wed Sep 20 10:18:43 CST 2023, time=2023-09-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1063446, encodeId=f96a1063446fd, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：多糖综述<br>经验分享：10月10号投稿，过去半个月了，现在还在With Editor，请问这种情况可以联系编辑吗？怎么联系呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62081980628, createdName=1e180d0dm79(暂无匿称), createdTime=Sun Oct 24 14:32:17 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106235, encodeId=347b210623503, content=投稿一个月了，还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211226/b81eecd114f947a4b95c452618e5ebdc/32dc8969e6744e21929a0d643f10b777.jpg, createdBy=404c107315, createdName=Marvin2014, createdTime=Thu Dec 15 20:44:34 CST 2022, time=2022-12-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=950107, encodeId=c72995010e59, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:3000.0<br>偏重的研究方向：蛋白;结构<br>经验分享：我的投稿速度应该算是这个杂志的平均速度。<br>投出去一天with editor；<br>5天under review；<br>14天获得外省意见；<br>22天major review，给了28天修回；<br>二审20天，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90331723198, createdName=璎, createdTime=Mon Mar 22 14:56:24 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861661, encodeId=c8378616612b, content=审稿速度:3.0<br>经验分享：2020.3.15 submit，with editor，4天<br> 2020.3.19 under review，25天<br> 2020.4.9 revision request（major revision），两个审稿人 提了10左右问题,14天<br> 2020.4.22 re-submit，with editor，1天<br> 2020.4.23 under review， 45天<br> 2020.6.8 accept<br> 编辑效率非常高，总体挺顺利的 ，祝大家文章都能早日接收，期刊越办越好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6f95414014, createdName=ms9686134410729756, createdTime=Wed Jun 10 06:33:48 CST 2020, time=2020-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向：分子生物学<br>经验分享：投稿第三天直接decision in process 请问这是直接拒稿吗？有没有相同经历的人 麻烦分享一下 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=806078, encodeId=ed098060e89d, content=我这为什么昨天刚投稿，今天就是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f945319034, createdName=148a44dcm02暂无昵称, createdTime=Tue Aug 04 10:21:36 CST 2020, time=2020-08-04, status=1, ipAttribution=)]
    2020-08-04 148a44dcm02暂无昵称

    我这为什么昨天刚投稿，今天就是under review

    6

    展开6条回复
共437条页码: 1/44页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分